Cenobamate: real-world data from a retrospective multicenter study.
Stephan LauxmannDavid HeuerJan HeckelmannFlorian P FischerMelanie SchreiberElisabeth SchriewerGuido WidmanYvonne WeberHolger LercheMichael AlberSigrid Schuh-HoferStefan WolkingPublished in: Journal of neurology (2024)
Adjunctive cenobamate was not associated with clinically significant changes in weight from baseline in patients treated for 1 and 2 years, including those receiving concomitant valproate, gabapentin, or pregabalin.